Table 4. Last day of DOAC intake before an elective intervention: day 0 is the day of surgery/procedure (modified from Steffel et al, 1 EHRA Practical Guide) .
Dabigatran | Apixaban–rivaroxaban–edoxaban | |||
---|---|---|---|---|
Low bleeding risk | High bleeding risk | Low bleeding risk | High bleeding risk | |
eGFR ≥ 80 mL/min | Day 2 | Day 3 | Day 2 | Day 3 |
eGFR = 50–80 mL/min | Day 2/3 (>36 h) | Day 4 | Day 2 | Day 3 |
eGFR = 30–50 mL/min | Day 3 | Day 5 | Day 2 | Day 3 |
eGFR = 15–30 mL/min | Contraindicated | Contraindicated | Day 2/3 (>36 h) | Day 3 |
Abbreviations: eGFR, estimated glomerular filtration rate; h, hour; min, minute.